Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diabetes, antidiabetic medications and risk of dementia: A systematic umbrella review and meta‐analysis
Alvin Kuate Defo, Veselko Bakula, Alessandro Pisaturo, et al.
Diabetes Obesity and Metabolism (2023) Vol. 26, Iss. 2, pp. 441-462
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Y J Youn, Seung Yeon Kim, Hyun‐Jeong Jeong, et al.
Frontiers in Neuroendocrinology (2024) Vol. 73, pp. 101131-101131
Open Access | Times Cited: 20
Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40-69 years with type 2 diabetes: population based cohort study
Anna Shin, Bo Kyung Koo, Jun Young Lee, et al.
BMJ (2024), pp. e079475-e079475
Open Access | Times Cited: 16
Assessment of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and other antidiabetic agents in Alzheimer’s disease: A population-based study
Mar Garcia-Zamora, Gemma García‐Lluch, Lucrecia Moreno, et al.
Pharmacological Research (2024) Vol. 206, pp. 107295-107295
Open Access | Times Cited: 13
Association of Metformin use with risk of dementia in patients with type 2 diabetes: A systematic review and meta‐analysis
Chunbian Tang, Jiayi Hao, Fengran Tao, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access | Times Cited: 1
Comparative Effectiveness of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Preventing Alzheimer's Disease, Vascular Dementia, and Other Dementia Types Among Patients with Type 2 Diabetes
Mingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.
Diabetes & Metabolism (2025), pp. 101623-101623
Closed Access | Times Cited: 1
Metformin’s Effects on Cognitive Function from a Biovariance Perspective: A Narrative Review
Dimitrie Chele, Carmen Adella Sîrbu, Marian Mitrică, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1783-1783
Open Access | Times Cited: 1
The pharmacodynamics-based prophylactic benefits of GLP-1 receptor agonists and SGLT2 inhibitors on neurodegenerative diseases: evidence from a network meta-analysis
Ping‐Tao Tseng, Bing‐Yan Zeng, Chih-Wei Hsu, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Glucose Transport and Utilization in the Hippocampus: From Neurophysiology to Diabetes-Related Development of Dementia
Caio Yogi Yonamine, Maria Luiza Estimo Michalani, Rafael Junges Moreira, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16480-16480
Open Access | Times Cited: 17
Repurposing antidiabetic drugs for Alzheimer's disease: A review of preclinical and clinical evidence and overcoming challenges
Jacky Tran, Sneh Parekh, Julia Rockcole, et al.
Life Sciences (2024) Vol. 355, pp. 123001-123001
Closed Access | Times Cited: 8
Association of sodium‐glucose cotransporter 2 inhibitors with risk of incident dementia and all‐cause mortality in older patients with type 2 diabetes: A retrospective cohort study using the TriNetX US collaborative networks
Yen‐Wei Pai, I‐Chieh Chen, Jun‐Fu Lin, et al.
Diabetes Obesity and Metabolism (2024)
Closed Access | Times Cited: 8
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Yogita Dhas, Nupur Biswas, M R Divyalakshmi, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 6
Insulin Resistance, a Risk Factor for Alzheimer’s Disease: Pathological Mechanisms and a New Proposal for a Preventive Therapeutic Approach
Flora Affuso, Filomena Micillo, Sergio Fazio
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1888-1888
Open Access | Times Cited: 5
Cognitive dysfunction in diabetes – the ‘forgotten’ diabetes complication: a narrative review
Åke Sjöholm, Louise Bennet, Peter M. Nilsson
Scandinavian Journal of Primary Health Care (2025), pp. 1-7
Open Access
Use of sodium‐glucose cotransporter‐2 inhibitors and risk of dementia: A population‐based cohort study
Lin Zhuo, Baixue Zhang, Yueqi Yin, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Managing dementia and diabetes in primary care settings
David L. Morris
Independent Nurse (2025) Vol. 2025, Iss. 2, pp. 22-25
Closed Access
Risk of depression and dementia among individuals treated with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists
Osvaldo P. Almeida
Current Opinion in Psychiatry (2025)
Closed Access
Glucagon-like peptide-1 receptor agonists for major neurocognitive disorders
Riccardo De Giorgi, Ana Ghenciulescu, Courtney Yotter, et al.
Journal of Neurology Neurosurgery & Psychiatry (2025), pp. jnnp-335593
Closed Access
Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure
Matteo Armillotta, Francesco Angeli, Pasquale Paolisso, et al.
Pharmacology & Therapeutics (2025) Vol. 270, pp. 108861-108861
Open Access
Diabetes and dementia: current data
N.V. Pashkovska, V.M. Pashkovskyy
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) (2025) Vol. 21, Iss. 2, pp. 215-225
Open Access
Anti-diabetic agents and the risks of dementia in patients with type 2 diabetes: a systematic review and network meta-analysis of observational studies and randomized controlled trials
Zonglin Li, Chu Lin, Xiaoling Cai, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
A multi-state analysis of disease trajectories and mental health transitions in patients with type 2 diabetes: A population-based retrospective cohort study utilizing health administrative data
Jacopo Lenzi, Rossella Messina, Simona Rosa, et al.
Diabetes Research and Clinical Practice (2024) Vol. 209, pp. 111561-111561
Open Access | Times Cited: 2
Downregulation of Iron–Sulfur Cluster Biogenesis May Contribute to Hyperglycemia-Mediated Diabetic Peripheral Neuropathy in Murine Models
Lin Wu, Fei Huang, Zichen Sun, et al.
Antioxidants (2024) Vol. 13, Iss. 9, pp. 1036-1036
Open Access | Times Cited: 2
Metformin as a Potential Prevention Strategy for Alzheimer’s Disease and Alzheimer’s Disease Related Dementias
Mouna Tahmi, R. Michael Benitez, José A. Luchsinger
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S345-S356
Closed Access | Times Cited: 2
Autophagy and mitophagy as potential therapeutic targets in diabetic heart condition: Harnessing the power of nanotheranostics
Sagnik Nag, Oishi Mitra, Bhanu Maturi, et al.
Asian Journal of Pharmaceutical Sciences (2024) Vol. 19, Iss. 3, pp. 100927-100927
Open Access | Times Cited: 1
Association between Alzheimer’s disease and metabolic syndrome: Unveiling the role of dyslipidemia mechanisms
Chenyu Yue, Yan Fu, Yongli Zhao, et al.
(2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top